According to these findings, it is concluded that the ferroptosis-related prognosis model based on LIFR, TP53, NRAS, and OSBPL9 may be a robust tool for forecasting the prognosis of MYCN-amplified NB patients. This evidence concerns the gene MYCN and neuroblastoma.